Molecular Hybridization as a Tool in the Design of Multi-target Directed Drug Candidates for Neurodegenerative Diseases

Abstract

Neurodegenerative Diseases (NDs) are progressive multifactorial neurological pathologies related to neuronal impairment and functional loss from different brain regions. Currently, no effective treatments are available for any NDs, and this lack of efficacy has been attributed to the multitude of interconnected factors involved in their pathophysiology. In the last two decades, a new approach for the rational design of new drug candidates, also called multitarget-directed ligands (MTDLs) strategy, has emerged and has been used in the design and for the development of a variety of hybrid compounds capable to act simultaneously in diverse biological targets. Based on the polypharmacology concept, this new paradigm has been thought as a more secure and effective way for modulating concomitantly two or more biochemical pathways responsible for the onset and progress of NDs, trying to overcome low therapeutical effectiveness. As a complement to our previous review article (Curr. Med. Chem. 2007, 14 (17), 1829-1852. https://doi.org/10.2174/092986707781058805), herein we aimed to cover the period from 2008 to 2019 and highlight the most recent advances of the exploitation of Molecular Hybridization (MH) as a tool in the rational design of innovative multifunctional drug candidate prototypes for the treatment of NDs, specially focused on AD, PD, HD and ALS.

Study of microbiome changes in patients with ulcerative colitis in the Central European part of Russia

“…The literature data we studied the role of Phascolarctobacterium succinatutens did not cover in the development of any types of IBD, including UC. P. succinatutens is known to be able to utilize succinate and produce propionate [ 48 ], which has anti-inflammatory and antitumor effects [ 49 ]. In this regard, further research is needed to determine the contribution of P. succinatutens to the system of metabolic interaction of intestinal microbiota.…”

Can phytotherapy with polyphenols serve as a powerful approach for the prevention and therapy tool of novel coronavirus disease 2019 (COVID-19)?

“…As a polyphenolic phytochemical, curcumin can modulate dendritic cells (DCs) and transform them into tolerogenic DCs with anti-inflammatory and immunomodulatory activities in health and disease ( 174 ). Accordingly, curcumin impedes the maturation and migration of cytokines and chemokines while disturbing the antigen-presenting machinery of DCs, rendering them non- or hyporesponsive to immunostimulants ( 80 ). These alterations may be due to the downregulation of transcription factors, including NF-κB, AP-1, MAPKs (p38, JNK, ERK), and other intracellular signaling molecules such as JAK/STAT/SOCS ( 171 ).…”

Current Approaches and Tools Used in Drug Development against Parkinson’s Disease

“…These concepts significantly impacted the treatment of neurodegenerative diseases such as PD. Interestingly, recently, the screening approach has been widely used in the development of multi-target ligands useful in the treatment of neurodegenerative disorders [ 60 , 61 , 62 , 63 , 64 , 65 , 66 ]. Jaiteh et al performed molecular docking screens against the binding sites of A 2A adenosine receptor and monoamine oxidase B (MAO-B) to identify dual inhibitors of these targets.…”